Veru
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Veru sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Veru: 10 sponsored US clinical trials, 1 recruiting.
Veru sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 4 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is SARS-CoV Infection, with 1 trials.
Top-decile sponsor footprint
Veru ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
NCT07446998
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
NCT06282458
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
NCT05065411
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
NCT04869943
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent
NCT04844749
To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer
NCT04843319
VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
NCT04842747
COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111
NCT04388826
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
NCT03752099
Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
NCT03646162
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 3 | 4 |
Therapeutic Areas
What is open in the Veru pipeline
1 recruiting of 10 indexed (10% open); 4 completed (40%).
Phase mix: 4 late (III/IV) vs 6 early (I/II) (balanced across stages).
Top condition: SARS-CoV Infection (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Veru: open-pipeline peers nationwide
Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Veru sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Abiomed · 10% recruiting · 20 trials
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Alzheimer's Disease Cooperative Study (ADCS) · 10% recruiting · 10 trials
Related
What to do with this Veru page
10 registered trials is a research-attention snapshot, not an endorsement of Veru or any single study.
- 1 of Veru's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- SARS-CoV Infection is the condition Veru studies most, compare against other sponsors active in the same condition before evaluating a specific study. See SARS-CoV Infection trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Veru pipeline card: 10 registered trials from official public datasets.Report a data error.